Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient

Transplantation

Volumn 61, Issue 12, 1996, Pages 1771-1774

  Marks, William H ^a   Florence, Lisa ^a   Lieberman, Joshua ^a   Chapman, Phillip ^a   Howard, Donald ^a,b   Roberts, Paul ^a   Perkinson, Diana ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AZATHIOPRINE; CANNABIS; CEFUROXIME; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; GANCICLOVIR; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LUNG ASPERGILLOSIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOKING AND SMOKING RELATED PHENOMENA; THORAX RADIOGRAPHY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; HUMANS; ITRACONAZOLE; KIDNEY TRANSPLANTATION; LUNG DISEASES, FUNGAL; MALE; MARIJUANA SMOKING; MIDDLE AGED; RISK FACTORS;

EID: 0029901892     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606270-00018     Document Type: Article

References (12)

1. Denning DW, Fallansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immuno-deficiency syndrome. N Engl J Med 1991; 324: 654.
2. Chusid MJ, Gelfand JA, Nutter C, Fauci AS. Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. Ann Int Med 1975; 82: 682.
3. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest 1988; 94: 432.
4. Sutton S, Lum BL, Torti FM. Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer. Drug Intell Clin Pharm 1986; 20: 289.
5. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147.
6. Weiland DW, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1973; 198: 622.
7. Gurwith MJ, Stinson EB, Remington JS. Aspergillus infection complicating cardiac transplantations: report of five cases. Arch Int Med 1971; 128: 541.
8. Kusne S, Torre-Cismeros J, Manez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive aspergillus culture after liver transplantation. J Infect Dis 1992; 166: 1379.
9. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH Jr. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983; 148: 230.
10. Kagen SL. Aspergillus: an inhalable contaminant of marihuana. N Engl J Med 1981; 304: 483.
11. Hay RJ. Liposomal amphotericin B, AmBisome. J Infect 1994; 28 (suppl 1): 35.
12. Lopez-Berestein G. Liposomal Amphotericin B in the treatment of fungal infections. Ann Int Med 1986; 105: 130.